Geometry.Net - Health_Conditions: Neuroleptic Malignant Syndrome

Facts You Should Know About NMS
Facts You Should Know About NMS neuroleptic malignant syndrome (NMS).What is NMS? NMS is characterized by development of muscle
http://www.dpw.state.pa.us/omr/omrNewmns.asp

Extractions: NEUROLEPTIC MALIGNANT SYNDROME (NMS) What is NMS? NMS is characterized by development of muscle rigidity and fever after taking an antipsychotic medication. There can also be changes in mental alertness, difficulty with drooling or swallowing, problems with blood pressure and sweating. What causes NMS? It is a rare but serious side effect of a drug from a category called neuroleptics or antipsychotics. These are typically used to treat psychotic disorders like schizophrenia. When does NMS occur? Typically, symptoms appear in the first 2 weeks after starting a neuroleptic or increasing the dosage of a neuroleptic. It may develop over hours or a few days. It also may occur at any time while on the medicine. Who is most likely to develop NMS?
Health Library - Neuroleptic Malignant Syndrome
Your Health, Advanced Search. neuroleptic malignant syndrome. Synonyms Disorder SubdivisionsGeneral Discussion Resources National Organization for Rare Disorders.
http://www.tetonhospital.org/library/healthguide/IllnessConditions/topic.asp?hwi
Psychiatrische Klinik Und Poliklinik- Projekt 3.5500.011
Translate this page The neuroleptic malignant syndrome. The neuroleptic malignant syndrome is a rarecomplication during therapy with neuroleptic and other psychotropic drugs.
http://www.zv.uni-wuerzburg.de/forschungsbericht/e03/e035500/p011.htm
JEFF MANN'S EM GUIDEMAPS - NEUROLEPTIC SYNDROME
Appendix. Research criteriae for neuroleptic malignant syndrome (from DSMIV). Alternativecriteriae for the diagnosis of neuroleptic malignant syndrome.
http://www.homestead.com/emguidemaps/files/rigidity.htm

Extractions: EM guidemap - Fever + rigidity + altered LOC Click on any of the headings or subheadings to rapidly navigate to the relevant section of the guidemap Introduction History of the present illness Summary of the clinical features differentiating NMS from SS Diagnostic testing ... Appendix Introduction - this guidemap has been designed to help an ED physician solve the diagnostic dilemma of "fever + rigidity + altered LOC" in an ED patient - this guidemap is mainly focused on helping the physician differentiate between neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) , with a lesser emphasis on other common causes of "fever + rigidity + altered LOC" History of the present illness - NMS usually develops over 24 - 72 hours , although it may progress more slowly over many days (3 - 10 days) in a patient taking a neuroleptic medication (* SS develops more abruptly within hours of a change in the dose of a provoking drug, or following the addition of an interacting drug eg. IM meperidine administered to a patient taking a MAOI) - NMS typically begins with mental status changes and muscular rigidity => hyperthermia and autonomic dysfunction - the mental status in NMS is always impaired and ranges from agitation => stupor => coma (* SS is usually associated with anxiety, restlessness , agitation or hypomania; and rarely with seizures or stupor/coma - the increased anxiety may be falsely misinterpreted as an exacerbation of the underlying condition requiring treatment with a SSRI)
Neuroleptic Malignant Syndrome During Olanzapine And Levomepromazine Treatment
Julkaisu. Reference. Järventausta K, Leinonen E. Neuroleptic malignantsyndrome during olanzapine and levomepromazine treatment.
http://www.hytti.uku.fi/tays/julkaisut/2000/200000438.html
Directory :: Look.com
neuroleptic malignant syndrome (6) See Also. Sites. Emergency Medicine An in depthlook at neuroleptic malignant syndrome beginning with an introduction.
http://www.look.com/searchroute/directorysearch.asp?p=595060
9.3.b. Bibliografia. Síndromes Hipertérmicos
8494 48.-LEIPSIC J ABRAHAM HD., HALPERIN P. neuroleptic malignant syndrome in theelderly Journal of Geriatric Psichiat and Neurol 1995; 828-31 49.- YOUNG
http://www.uninet.edu/tratado/c0903b.html
Virtual Naval Hospital: Emergency Psychiatry Service Handbook: Major Emergencies
Medical Emergencies in Psychiatry neuroleptic malignant syndrome.Gerard Clancy, MD Peer Review Status Internally Peer Reviewed
http://www.vnh.org/EmergPsychHB/MedEmergNMS.html

Extractions: Fever, rigidity, diaphoresis, dysphagia, labile blood pressure, increased pulse rate, altered mental state (delirium), increased white blood count, increased CPK, SGOT and LDH. Onset is relatively sudden hours to days, which helps distinguish NMS from Lethal Catatonia. Treatment: Obtain medical consultation due to high mortality. Discontinue the antipsychotic immediately.
© POL.it 2001 AREA PSICOFARMACOLOGIA / CLOZAPINA
Translate this page Anderson ES, Powers PS. neuroleptic malignant syndrome associated width clozapineuse. Das Gupta K, Young A. Clozapine-induced neuroleptic malignant syndrome.
http://www.pol-it.org/ital/clozapina/smn.htm

Extractions: BIBLIOGRAFIA Anderson ES, Powers PS. Neuroleptic malignant syndrome associated width clozapine use. J Clin Psychiatry 1991; 52: 102-104. Cassano GB, Lambertenghi Deliliers G, Pancheri P, Racagni G. Rivista di Psichiatria 1996; 31, 4(SUPPL): 9. Das Gupta K, Young A. Clozapine-induced neuroleptic malignant syndrome. J Clin Psychiatry 1991; 52: 105-107. Miller DD. Sharafuddin MJA, Kathol RG. A case of clozapine-induced neuroleptic malignant syndrome. J Clin Psychiatry 1991; 52: 23-25. Neuroleptic malignant syndrome after clozapine plus carbamazepine . Lancet 1988; 2: 1500. Pope HG, Cole JO, Chopas PT. Apparent neuroleptic malignant syndrome associated width cloapine and lithium J Nerv Ment Dis 1986; 174: 493-495. Repo E, Lepola U, Koponen H. Neuroleptic malignant syndrome. Five cases and a review. Nord Psychiatr Tidsskr 1989; 43: 475-478. Stoudemire A, Clayton. Successfull use of clozapine in a patient with a history of neuroleptic malignant syndrome. J Neuropsychatry 1989; 1: 303-305.
SEROTONIN SYNDROME
This disorder, brought on by excessive levels of serotonin, is difficult to distinguishfrom the neuroleptic malignant syndrome because the symptoms are so
http://members.aol.com/atracyphd/syndrome.htm

Extractions: "The symptoms of the serotonin syndrome are: euphoria, drowsiness, sustained rapid eye movement, overreaction of the reflexes, rapid muscle contraction and relaxation in the ankle causing abnormal movements of the foot, clumsiness, restlessness, feeling drunk and dizzy, muscle contraction and relaxation in the jaw, sweating, intoxication, muscle twitching, rigidity, high body temperature, mental status changes were frequent (including confusion and hypomania - a "happy drunk" state), shivering, diarrhea, loss of consciousness and death. (The Serotonin Syndrome, AM J PSYCHIATRY, June 1991)
Www3.health-center.com: Side Effects And Risks: Does Clozapine Cause NMS?
Does clozapine cause NMS? Clozapine is an atypical neuroleptic drug that wasinitially thought not to cause neuroleptic malignant syndrome (NMS).
http://www3.health-center.com/pharmacy/antipsychotics/clozapine/side_effects_a/n

Extractions: Does clozapine cause NMS? Clozapine is an atypical neuroleptic drug that was initially thought not to cause neuroleptic malignant syndrome (NMS). Clozapine is now known to produce neuroleptic malignant syndrome. To date 14 cases have been reported. Can clozapine be used as treatment in cases of NMS? Clozapine has been used in patients with previous history of NMS (Weller, 1992, 8 cases) and also been successfully re-challenged after 6 months in a case of NMS due to clozapine (Chatterton, 1996), however caution is advised by these authors. References: Karagianis JL, Phillips LC, Hogan KP, LeDrew KK (1999). Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
TD Tardive Dyskinesia NMS Neuroleptic Malignancy Syndrome
The NAMI/NYCMetro Web Site has moved to Please change your bookmarks and links. * * * The Schizophrenia Home Page is still at * * * You are also invited to visit the Treatment Advocacy Center
http://www.schizophrenia.com/ami/meds/sidefx.html
An Analysis Of 17 Catatonic Patients Diagnosed With Neuroleptic Malignant Syndro
TABLE 1. SUMMARY OF 17 CATATONIC PATIENTS DIAGNOSED WITH NEUROLEPTICMALIGNANT syndrome. Case, Age, Sex, Preneuroleptic Diagnosis (DSM
http://www.medicalbroadcast.com/CMEReviews/catatonia/white1.html

Extractions: TABLE 1. SUMMARY OF 17 CATATONIC PATIENTS DIAGNOSED WITH NEUROLEPTIC MALIGNANT SYNDROME Case Age, Sex Preneuroleptic Diagnosis (DSM III-R) Neuroleptic Dosage Postneuroleptic Diagnosis Time Lag to NMS After Initial Neuroleptic Dose Treatment Duration of NMS Outcome Post-NMS Diagnosis (DSM III-R) 25, F CM, CE Clothiapine 80mg, 2 doses IV NMS 72 hours Diazepam 14 days Recovered Nil CM, CE 20, M Clothiapine 80mg, 2 doses IV NMS 48 hours Diazepam 10 days Recovered Atypical psychosis 20, M CM, CE Clothiapine 80mg, 3 doses IV NMS 24 hours Diazepam 12 days Recovered BAD (manic) 48, F CM, CE Chlorpromazine 100mg, 1 dose IM NMS 48 hours Bromocriptine 20 days Recovered Depression 33, F CM, CE Clothiapine 80 mg, 1 dose IM NMS 48 hours Bromocriptine 10 days Recovered Nil 32, F CM, CE Haloperidol 10 mg, 1 dose IM NMS 24 hours Diazepam 7 days Recovered Nil 22, M CM, CE Haloperidol 10 mg, 6 doses PO NMS 48 hours Diazepam 5 days Recovered BAD (manic) 30, M CM, CE Fluphenazine decanoate 75 mg, 1 dose IM NMS 96 hours Bromocriptine 16 days Recovered Schizoaffective disorder 23, M
Katalog - Wirtualna Polska
Serwis Katalog w Wirtualna Polska S.A. pierwszy portal w Polsce.
http://katalog.wp.pl/DMOZ/Health/Conditions_and_Diseases/Neurological_Disorders/
PowerPoint v[e[V - ««ÇóQ (neuroleptic Ma
The summary for this Japanese page contains characters that cannot be correctly displayed in this language/character set.
http://www1.linkclub.or.jp/~och-gim/NMS grand round.htm

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

81-95 of 95 Back | 1 | 2 | 3 | 4 | 5